Earnings History Data for Roivant Sciences Ltd. (ROIV) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Roivant Sciences Ltd.

Roivant Sciences is a biopharmaceutical company dedicated to improving the delivery of healthcare to patients. Roivant Sciences, formerly known as Montes Archimedes Acquisition Corp., is based in NEW YORK.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
10-02-2025	PM		ROIV	Roivant Sciences Ltd.	7,910	-0.20	-0.30	-0.26	Roivant Sciences reports Q3 results [2/10/2025 8:43 AM]	10.78	-0.12 (-1.06%)	11.35	0.46 (4.22%)	9.76 - 13.06	4,057,330	3,650,000	6,582
Roivant Sciences reports Q3 results [2/10/2025 8:43 AM] Roivant Sciences targets brepocitinib expansion with new cutaneous sarcoidosis trial amid $5.2B cash position [2/10/2025 12:32 PM] Roivant Reports Financial Results for the Third Quarter Ended December 31, 2024, and Provides Business Update [2025-02-10 07:00AM] What To Expect From Roivant Sciences Ltd (ROIV) Q3 2025 Earnings [Feb-07-25 07:06AM]
12-11-2024	PM		ROIV	Roivant Sciences Ltd.	8,780	-0.37	-0.27	-0.33	Roivant Sciences GAAP EPS of -$0.25, revenue of $4.48M [11/12/2024 7:20 AM]	11.63	-0.18 (-1.48%)	11.73	-0.08 (-0.68%)	8.47 - 13.06	4,039,860	3,560,000	10,452
Roivant Sciences GAAP EPS of -$0.25, revenue of $4.48M [11/12/2024 7:20 AM] Roivant Reports Financial Results for the Second Quarter Ended September 30, 2024, and Provides Business Update [2024-11-12 07:00AM] Roivant Sciences Ltd (ROIV) Q2 2025 Earnings Report Preview: What To Expect [Nov-11-24 07:04AM]
08-08-2024	PM		ROIV	Roivant Sciences Ltd.	7,630	-0.24	-0.27	-0.38	Roivant Sciences GAAP EPS of $0.12 beats by $0.38, revenue of $55.13M beats by $25.54M [8/8/2024 7:32 AM]	10.84	0.67 (6.54%)	10.50	0.33 (3.24%)	8.24 - 13.24	5,366,969	3,970,000	8,035
Roivant Sciences Q1 2025 Earnings Preview [8/7/2024 11:04 AM] Roivant Sciences GAAP EPS of $0.12 beats by $0.38, revenue of $55.13M beats by $25.54M [8/8/2024 7:32 AM]
30-05-2024	PM		ROIV	Roivant Sciences Ltd.	8,730	-0.28	-0.31	-0.20	Roivant Sciences GAAP EPS of -$0.19 beats by $0.11, revenue of $28.93M misses by $2.01M [5/30/2024 7:08 AM]	10.41	-0.32 (-2.94%)	10.84	0.11 (1.03%)	8.24 - 13.24	9,489,143	4,430,000	3,394
Roivant Sciences Q4 2024 Earnings Preview [5/29/2024 1:50 PM] Roivant Sciences GAAP EPS of -$0.19 beats by $0.11, revenue of $28.93M misses by $2.01M [5/30/2024 7:08 AM]
13-02-2024	PM		ROIV	Roivant Sciences Ltd.	8,690	-0.26	-0.33	-0.49	Roivant Sciences GAAP EPS of $6.03 beats by $5.54, revenue of $37.14M beats by $7.32M [2/13/2024 7:06 AM]	10.82	-0.05 (-0.46%)	10.95	0.08 (0.74%)	6.59 - 13.24	4,925,396	5,340,000	23,331
Roivant Sciences Q3 2024 Earnings Preview [2/12/2024 12:44 PM] Roivant Sciences GAAP EPS of $6.03 beats by $5.54, revenue of $37.14M beats by $7.32M [2/13/2024 7:06 AM]
13-11-2023	PM		ROIV	Roivant Sciences Ltd.	6,600	-0.33	-0.32	-0.42	Roivant Sciences GAAP EPS of -$0.40 misses by $0.09, revenue of $37.1M beats by $9.98M [11/13/2023 7:03 AM]	9.04	0.23 (2.67%)	8.75	-0.06 (-0.68%)	4.71 - 13.24	3,314,768	5,290,000	20,512
Roivant Sciences GAAP EPS of -$0.40 misses by $0.09, revenue of $37.1M beats by $9.98M [11/13/2023 7:03 AM]
14-08-2023	PM		ROIV	Roivant Sciences Ltd.	8,640	-0.38	-0.26	-0.48	Roivant Sciences GAAP EPS of -$0.38 misses by $0.07, revenue of $21.62M misses by $2.87M [8/14/2023 7:27 AM]	11.70	0.12 (1.08%)	11.55	-0.02 (-0.17%)	2.87 - 12.01	3,099,127	3,030,000	80,850
Roivant Sciences GAAP EPS of -$0.38 misses by $0.07, revenue of $21.62M misses by $2.87M [8/14/2023 7:27 AM]
28-06-2023	PM	7:00 AM ET (Jun 28)	ROIV	Roivant Sciences Ltd.	7,430	-0.20	-0.44	-0.39	Roivant Sciences GAAP EPS of -$0.20 beats by $0.18, revenue of $27.38M beats by $9.18M [6/28/2023 7:24 AM]	10.05	1.00 (11.05%)	9.26	0.21 (2.32%)	2.87 - 10.83	7,774,099	8,430,000	12,433
Roivant Sciences FQ4 2023 Earnings Preview [6/27/2023 11:38 AM] Roivant Sciences GAAP EPS of -$0.20 beats by $0.18, revenue of $27.38M beats by $9.18M [6/28/2023 7:24 AM]
13-02-2023	PM	7:00 AM ET (Feb 13)	ROIV	Roivant Sciences Ltd.	5,840	-0.49	-0.36	-0.41	Roivant Sciences GAAP EPS of -$0.49 misses by $0.09, revenue of $17.05M beats by $2.27M [2/13/2023 7:39 AM]	8.12	0.15 (1.82%)	7.88	-0.09 (-1.13%)	2.52 - 10.00	1,501,855	2,870,000	11,212
Roivant Sciences GAAP EPS of -$0.49 misses by $0.09, revenue of $17.05M beats by $2.27M [2/13/2023 7:39 AM] Roivant Sciences founder Ramaswamy considering 2024 presidential run - POLITICO [2/13/2023 12:33 PM]
14-11-2022	PM	7:00 AM ET (Nov 14)	ROIV	Roivant Sciences Ltd.	3,650	-0.42	-0.41	-0.87	Roivant Sciences GAAP EPS of -$0.42 misses by $0.01, revenue of $12.53M beats by $6.83M [11/14/2022 7:30 AM]	5.30	0.14 (2.71%)	5.40	0.24 (4.65%)	2.52 - 16.76	2,075,554	1,840,000	7,616
Roivant Sciences GAAP EPS of -$0.42 misses by $0.01, revenue of $12.53M beats by $6.83M [11/14/2022 7:30 AM]
15-08-2022	PM	6:10 AM ET (Aug 15)	ROIV	Roivant Sciences Ltd.	3,010	-0.48	-0.30	-0.37	Roivant Sciences GAAP EPS of -$0.48, revenue of $4.32M [8/15/2022 7:46 AM]	4.22	-0.14 (-3.32%)	4.40	0.03 (0.69%)	2.52 - 16.76	976,446	850,000	526
Roivant Sciences GAAP EPS of -$0.48, revenue of $4.32M [8/15/2022 7:46 AM] Roivant Sciences Reports Financial Results for the First Quarter Ended June 30, 2022 and Provides Business Update [Aug-15-22 07:00AM]
28-06-2022	PM	7:00 AM ET (Jun 28)	ROIV	Roivant Sciences Ltd.	3,230	-0.39	-0.25	0.00	Roivant Sciences GAAP EPS of -$0.39 misses by $0.09, revenue of $9.22M misses by $2.35M [6/28/2022 6:14 AM]	4.68	0.01 (0.11%)	4.95	0.27 (5.77%)	2.52 - 16.76	596,055	1,130,000	15,617
Roivant Sciences GAAP EPS of -$0.39 misses by $0.09, revenue of $9.22M misses by $2.35M [6/28/2022 6:14 AM] Roivant Sciences teams up with Pfizer to launch Priovant [6/28/2022 6:49 AM] Roivant axes gene therapy, dermatology and excessive sweating candidates from development [6/28/2022 10:12 AM] Roivant and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Studies for Oral Brepocitinib in Dermatomyositis and Lupus [Jun-28-22 06:00AM] Roivant Sciences Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2022 and Provides Business Update [Jun-28-22 06:10AM] Roivant, Pfizer unveil Priovant Therapeutics focused on autoimmune disease treatments, Roivant stock surges [Jun-28-22 06:27AM]
14-02-2022	PM	7:00 AM ET (Feb 14)	ROIV	Roivant Sciences Ltd.	5,030	-0.41	-0.23	0.00	Roivant Sciences GAAP EPS of -$0.41 misses by $0.17, revenue of $24.34M [2/14/2022 7:03 AM]	7.21	0.36 (5.26%)	6.85	0.0 (0.00%)	5.80 - 16.76	308,370	270,000	4,744
Roivant Sciences GAAP EPS of -$0.41 misses by $0.17, revenue of $24.34M [2/14/2022 7:03 AM] Roivant Sciences Reports Financial Results for the Quarter Ended December 31, 2021 and Provides Business Update [Feb-14-22 07:00AM]
15-11-2021	PM	Before the open (Nov 15)	ROIV	Roivant Sciences Ltd.	5,360	-0.87	-0.45	0.00	Roivant Sciences EPS beats by $0.15, beats on revenue [11/15/2021 7:33 AM]	8.03	-0.37 (-4.40%)	8.59	0.19 (2.26%)	5.80 - 10.87	508,173	370,000	271
Roivant Sciences EPS beats by $0.15, beats on revenue [11/15/2021 7:33 AM] Roivant Sciences Reports Financial Results for the Quarter Ended September 30, 2021 and Provides Business Update [Nov-15-21 07:00AM]